Market Commentary - Stock Alert
L&T, Dr Reddy's Labs, Adani Enterprises in spotlight As on : 11-May-23  08:37

L&T: The EPC major's consolidated net profit rose 10.11% to Rs 3,986.78 crore on 10.38% rise in revenue from operations to Rs 58,335.15 crore in Q4 FY23 over Q4 FY22. The order inflow for the quarter ended 31 March 2023 stood at Rs 76,099 crore, registering a growth of 3% over the corresponding quarter of the previous year.

Dr Reddy's Laboratories: The drug major reported consolidated net profit of Rs 959.2 crore in Q4 FY23, which was steeply higher than Rs 87.5 crore reported in Q4 FY22. Revenues increased 15.82% year on year to Rs 6,296.8 crore in the quarter ended 31 March 2023.

Adani Enterprises: The meeting of the board of directors of the company is scheduled on 13 May 2023 to consider and approve fund raising by way of issuance equity shares or any other eligible securities through permissible modes.

Godrej Consumer Products: The company reported consolidated net profit of Rs 452.14 crore in Q4 FY23 as compared to net profit of Rs 363.24 crore reported in Q4 FY22. Total income increased to Rs 3,258.07 crore in the quarter ended 31 March 2023 from Rs 2,939.58 crore in the quarter ended 31 March 2022.

KPI Green Energy: The company received a new order of 35 MW capacity Solar Power Plant under Captive Power Producer (CPP) Segment, in lieu of the previous order of 33 MW capacity Solar Power Plant.

RattanIndia Enterprises: The company has received board approval for raising of funds up to Rs 1000 crore through the issue of securities, either by way of qualified institutions placement (QIP) or any other permissible mode of fundraising.

Powered by Capital Market - Live News